文摘
Technologies for regulated expression of multiple transgenes in mammalian cells havegathered momentum for bioengineering, gene therapy, drug discovery, and gene-function analyses. Capitalizing on recently developed mammalian transgene modalities(QuoRex) derived from Streptomyces coelicolor, we have designed a flexible and highlycompatible expression vector set that enables desired transgene/siRNA control inresponse to the nontoxic butyrolactone SCB1. The construction-kit-like expressionportfolio includes (i) multicistronic (pTRIDENT), (ii) autoregulated, (iii) bidirectional(pBiRex), (iv) oncoretro- and lentiviral transduction, and (v) RNA polymerase II-basedsiRNA transcription-fine-tuning vectors for straightforward implementation of QuoRex-controlled (trans)gene modulation in mammalian cells.